| Identification | Back Directory | [Name]
Acetamide, 2-[[[4-[(2-bromo[1,1'-biphenyl]-3-yl)methoxy]-5-chloro-2-[(3-cyanophenyl)methoxy]phenyl]methyl](2-mercaptoethyl)amino]-N-(2-mercaptoethyl)- | [CAS]
2547100-02-5 | [Synonyms]
N2S2-CBMBC
Acetamide, 2-[[[4-[(2-bromo[1,1'-biphenyl]-3-yl)methoxy]-5-chloro-2-[(3-cyanophenyl)methoxy]phenyl]methyl](2-mercaptoethyl)amino]-N-(2-mercaptoethyl)- | [Molecular Formula]
C34H33BrClN3O3S2 | [MOL File]
2547100-02-5.mol | [Molecular Weight]
711.13 |
| Hazard Information | Back Directory | [Uses]
N2S2-CBMBC, an N2S2 bromo-benzyl ether derivative, acts as a ligand and use 99mTc-labelled complexes 99mTc-N2S2-CBMBC can be used as an imaging agent to be applied to the aspect of detecting PD-L1 expression, realize the real-time, comprehensive and convenient detection of the PD-L1 level of tumors, and overcome the defects of an immunohistochemical method[1]. | [References]
[1] Chunxiong Lu, et al. N2S2 bromo-benzyl ether derivative, preparation method and application. CN111943876A. |
|
|